Target Name: MCOLN3
NCBI ID: G55283
Review Report on MCOLN3 Target / Biomarker Content of Review Report on MCOLN3 Target / Biomarker
MCOLN3
Other Name(s): MGC71509 | Mucolipin-3 (isoform 1) | mucolipin 3 | OTTHUMP00000011616 | Transient receptor potential channel mucolipin 3 | MCOLN3 variant 1 | FLJ36629 | Mucolipin-3 | mucolipin TRP cation channel 3 | MCLN3_HUMAN | transient receptor potential channel mucolipin 3 | Mucolipin TRP cation channel 3, transcript variant 1 | OTTHUMP00000011617 | TRP-ML3 | TRPML3 | FLJ11006

MCOLN3: A Unique Protein with Potential as A Drug Target

MCOLN3 (MGC71509) is a protein that is expressed in various tissues of the body, including the brain, pancreas, and gastrointestinal tract. It is a member of the metal transmembrane protein family MCP family, which includes proteins that are involved in various cellular processes, including signaling, migration, and cytoskeletal organization.

One of the unique features of MCOLN3 is its structure. It is a type of transmembrane protein that consists of a catalytic center, a cytoplasmic tail, and an extracellular region that is involved in cell-cell and cell-extracellular signaling. The catalytic center of MCOLN3 contains a heme-containing domain that is involved in the production of reactive oxygen species (ROS), which can damage cellular components and contribute to various diseases, including neurodegenerative disorders and cancer.

MCOLN3 is also involved in the regulation of cellular processes that are important for maintaining tissue homeostasis, including cell migration and the formation of tight junctions. It is a component of several different signaling pathways that are involved in these processes, including the TGF-β pathway, which is involved in the regulation of cell growth and differentiation, and the Wnt pathway, which is involved in the regulation of cell-cell interactions and tissue patterning.

MCOLN3 is also of interest as a potential drug target. Its involvement in various cellular processes and its unique structure make it an attractive target for drug development. In addition, its expression is highly abundant in several diseases, including neurodegenerative disorders and cancer, which makes it an important biomarker for these conditions.

One of the potential strategies for targeting MCOLN3 is to use small molecules that can modulate its activity. For example, inhibitors of the heme-containing domain of MCOLN3 have been shown to be effective in reducing the production of ROS and protecting against cellular damage. Similarly, modulators of the cytoplasmic tail of MCOLN3 have been shown to affect its localization and stability in the cell.

Another approach to targeting MCOLN3 is to use antibodies that can specifically recognize and interact with it. This approach has been used to study its localization and stability in various cellular contexts, including the regulation of cell migration and the formation of tight junctions.

In addition to its potential as a drug target, MCOLN3 is also of interest as a biomarker. Its expression is highly abundant in several diseases, including neurodegenerative disorders and cancer, which makes it an important indicator of the disease state. In addition, its activity can be modulated by various factors, including the levels of ROS and the availability of oxygen. This makes it a potential marker for the monitoring of cellular stress and the assessment of therapeutic interventions.

In conclusion, MCOLN3 is a protein that is involved in various cellular processes and has the potential to be a drug target. Its unique structure and its involvement in multiple cellular processes make it an attractive target for drug development. Additionally, its high expression in several diseases makes it an important biomarker for these conditions. Further research is needed to fully understand its role in cellular processes and its potential as a drug target.

Protein Name: Mucolipin TRP Cation Channel 3

Functions: Nonselective ligand-gated cation channel probably playing a role in the regulation of membrane trafficking events. Acts as Ca(2+)-permeable cation channel with inwardly rectifying activity (PubMed:18369318, PubMed:19497048, PubMed:19522758, PubMed:19885840, PubMed:29106414). Mediates release of Ca(2+) from endosomes to the cytoplasm, contributes to endosomal acidification and is involved in the regulation of membrane trafficking and fusion in the endosomal pathway (PubMed:21245134). Does not seem to act as mechanosensory transduction channel in inner ear sensory hair cells. Proposed to play a critical role at the cochlear stereocilia ankle-link region during hair-bundle growth (By similarity). Involved in the regulation of autophagy (PubMed:19522758). Through association with GABARAPL2 may be involved in autophagosome formation possibly providing Ca(2+) for the fusion process (By similarity). Through a possible and probably tissue-specific heteromerization with MCOLN1 may be at least in part involved in many lysosome-dependent cellular events (PubMed:19885840). Possible heteromeric ion channel assemblies with TRPV5 show pharmacological similarity with TRPML3 (PubMed:23469151)

The "MCOLN3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MCOLN3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MCPH1 | MCPH1-AS1 | MCPH1-DT | MCRIP1 | MCRIP2 | MCRS1 | MCTP1 | MCTP2 | MCTS1 | MCTS2 | MCU | MCUB | MCUR1 | MDC1 | MDFI | MDFIC | MDGA1 | MDGA2 | MDH1 | MDH1B | MDH2 | MDK | MDM1 | MDM2 | MDM4 | MDN1 | MDS2 | ME1 | ME2 | ME3 | MEA1 | MEAF6 | MEAF6P1 | MEAK7 | Mechanoelectrical transducer (MET) channel | Mechanosensitive Ion Channel | MECOM | MECOM-AS1 | MeCP1 histone deacetylase (HDAC) complex | MECP2 | MECR | MED1 | MED10 | MED11 | MED12 | MED12L | MED13 | MED13L | MED14 | MED14P1 | MED15 | MED15P8 | MED16 | MED17 | MED18 | MED19 | MED20 | MED21 | MED22 | MED23 | MED24 | MED25 | MED26 | MED27 | MED28 | MED29 | MED30 | MED31 | MED4 | MED4-AS1 | MED6 | MED7 | MED8 | MED9 | MEDAG | Mediator Complex | Mediator of RNA Polymerase II Transcription | MEF2A | MEF2B | MEF2C | MEF2C-AS1 | MEF2C-AS2 | MEF2D | MEFV | MEG3 | MEG8 | MEG9 | MEGF10 | MEGF11 | MEGF6 | MEGF8 | MEGF9 | MEI1 | MEI4 | MEIG1 | MEIKIN | MEIOB | MEIOC | MEIOSIN | MEIS1